Phase I results support advancement of oral carbapenem SPR-994 into pivotal phase III trial in cUTI Sep. 28, 2018
Chitinase 3-like 1 protein as a novel therapeutic target in RSV-induced airway inflammation Sep. 28, 2018
Orphazyme reports topline phase II/III data on arimoclomol in Niemann-Pick disease Type C Sep. 28, 2018
RSS